Alzheimer's dementia;Die Alzheimer-demenz

Praxis

Volumn 89, Issue 13, 2000, Pages 529-540

  Hock, C ^a   Nitsch, R M ^a  

^a UNIVERSITY HOSPITAL OF PSYCHIATRY   (Switzerland)

Author keywords

Acetylcholinesterase inhibitor; Aging; Dementia; Environmental factors; Risk genes

Indexed keywords

AMYLOID; CHOLINESTERASE INHIBITOR;

AGING; ALZHEIMER DISEASE; COMPUTER ASSISTED TOMOGRAPHY; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; ELECTROENCEPHALOGRAM; ENVIRONMENTAL FACTOR; GENETIC ANALYSIS; GENETIC RISK; HUMAN; MENTAL DISEASE; NEUROPSYCHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOGENESIS; POSITRON EMISSION TOMOGRAPHY; REVIEW; RISK FACTOR; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; CHOLINESTERASE INHIBITORS; DIAGNOSIS, DIFFERENTIAL; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; RISK FACTORS;

EID: 0034704926     PISSN: 16618157     EISSN: 16618165     Source Type: Journal    
DOI: None     Document Type: Review

References (45)

1. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, Third Edition-Revised. Washington, DC, 1987.
2. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. Washington, DC, 1994.
3. Chui H.C., Victoroff J.I., Margolin D., Jagust W., Shankle R., Katzman R.: Criteria for the diagnosis of ischemic vascular dementia proposed by the State of California Alzheimer's Disease Diagnostic and Treatment Centers. Neurology, 42(3 Pt 1), 473-480, 1992.
4. Clinical and neuropathological criteria for frontotemporal dementia. The Lund and Manchester groups. J Neurol Neurosurg Psychiatry, 57, 416-418, 1994.
5. Corder E.H., Saunders A.M., Strittmatter W.J., Schmechel D.E., Gaskell P.C., Small G.W., Roses A.D., Haines J.L., Pericak-Vance M.A.: Gene Dose of Apolipoprotein E Type 4 Allele and the Risk of Alzheimer's Disease in Late Onset Families. Science, 261, 921-923, 1993. (Pubitemid 23275809)
6. Crook T., Larrabee G.J.: Age-associated memory impairment: diagnostic criteria and treatment strategies. Psychopharmacol Bull, 24(4), 509-514, 1988. (Pubitemid 19054354)
7. Cummings J.L.: The Neuropsychiatric Inventory. Neurology, 44, 2308-2314, 1994.
8. Davies L., Wolska B., Hilbich C., Multhaup G., Martins R., Simms G., Beyreuther K., Masters C.L.: Amyloid protein deposition and the diagnosis of Alzheimer's disease: prevalence in aged brains determined by immunocytochemistry compared with conventional neuropathologic techniques. Neurology, 38(11), 1688-1693, 1988. (Pubitemid 18265030)
9. Folstein M.F., Folstein S.E., McHugh P.R.: «Mini Mental State»- A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res, 12, 189-198, 1975.
10. Freedman M., Leach L., Kaplan E., Winocur G., Shulman K.I., Delis D.C.: Clock Drawing: A neuropsychological analysis. New York, Oxford: Oxford University Press, 1994.
11. Giacobini E.: Invited review: Cholinesterase inhibitors for Alzheimer's disease therapy: Cholinesterase inhibitors for Alzheimer's disease therapy: from tacrine to future applications. Neurochem Int, 32(5-6), 413-419, 1998.
12. Goedert M.: Neurofibrillary pathology of Alzheimer's disease and other tauopathies. Prog Brain Res, 117, 287-306, 1998.
13. Growdon J.H.: Treatment for Alzheimer's Disease? New England J of Medicine, 327, 1306-1308, 1992.
14. Hachinski V.C., Iliff L.D., Zilhka E., Du Boulay G.H., McAllister V.L., Marshall J., Russell R.W., Symon L.: Cerebral blood flow in dementia. Arch Neurol, 32(9), 632-637, 1975.
15. Helmes E., Merskey H., Fox H., Fry R.N., Bowler J.V., Hachinski V.C.: Patterns of deterioration in senile dementia of the Alzheimer type. Arch Neurol 52(3), 306-310, 1995.
16. Hennerici M.: Vascular dementia: A changing concept. Arzneimittelforschung, 45(3A), 366-370, 1995.
17. Hock C., Golombowski S., Naser W., Müller-Spahn F.: Increased levels of tau protein in cerebrospinal fluid of patients with Alzheimer's disease-correlation with degree of cognitive impairment. Ann Neurol, 37(3), 414-415, 1995.
18. Hock C., Müller-Spahn F.: Risikofaktoren der Alzheimer-Krankheit. In: Helmchen H., Henn F., Lauter H., Sartorius N. (eds) Psychiatrie der Gegenwart, 4. Auflage, Band 4, «Psychische Störungen bei somatischen Krankheiten», Springer Verlag, 105-115, 1999.
19. Hughes C.P., Berg L., Danziger W.L., Coben L.A., Martin R.L.: A new clinical scale for staging of dementia. Br J Psychiatry, 140, 566-572, 1982. (Pubitemid 12124384)
20. ICD-10. Weltgesundheitsorganisation, Internationale Klassifikation psychischer Störungen, Hrsg. H. Dilling, W. Mombour, M.H. Schmidt, Verlag H. Huber, Göttingen, 1991.
21. Jorm A.F., Korten A.E., Henderson A.S.: The prevalence of dementia: A quantitative integration of the literature. Acta Psych Scand, 76, 465-479, 1987. (Pubitemid 17164786)
22. Jorm A.F.: A short form of the Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE): development and cross-validation. Psychol Med, 24(1), 145-153, 1994.
23. Kaye J.A.: Diagnostic challenges in dementia. Neurology, 51(S1), S45-S52, 1998.
24. Locascio J.J., Growdon J.H., Corkin S.: Cognitive test performance in detecting, staging, and tracking Alzheimer's disease. Arch Neurol, 52(11), 1087-1099, 1995.
25. McKeith I.G., Galasko D., Kosaka K., Perry E.K., Dickson D.W., Hansen L.A., Salmon D.P., Lowe J., Mirra S.S., Byrne E.J., Lennox G., Quinn N.P., Edwardson J.A., Ince P.G., Bergeron C., Burns A., Miller B.L., Lovestone S., Collerton D., Jansen E.N., Ballard C., de Vos R.A., Wilcock G.K., Jellinger K.A., Perry R.H.: Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology, 47(5), 1113-1124, 1996. (Pubitemid 26374873)
26. McKhann G., Drachman D., Folstein M., Katzman R., Price D., Stadlan E.M.: Clinical diagnosis of Alzheimer's Disease: report of the NINCDS-ADRDA work group under the auspices of the Department of Health and Human Services Task Force in Alzheimer's Disease. Neurology, 34, 939-944, 1984. (Pubitemid 14076461)
27. Morris J.C., Heyman A., Mohs R.C., Hughes J.P., van Belle G., Fillenbaum G., Mellits E.D., Clark C., CERAD investigators: The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer's disease. Neurology, 39, 1159-1165, 1989. (Pubitemid 19239715)
28. Motter R., Vigo-Pelfrey C., Kholodenko D., Barbour R., Johnson-Wood K., Galasko D., Chang L., Miller B., Clark C., Green R., et al.: Reduction of beta-amyloid peptide42 in the cerebrospinal fluid of patients with Alzheimer's disease. Ann Neurol, 38(4), 643-648, 1995.
29. Nuwer M.: Assessment of digital EEG, quantitative EEG, and EEG brain mapping: report of the American Academy of Neurology and the American Clinical Neurophysiology Society. Neurology, 49(1), 277-292, 1997.
30. Ott A., Breteler M.M.B., van Harskamp F., Claus J.J., van der Cammen T.J.M., Grobbee D.E., Hofman A.: Prevalence of Alzheimer's disease and vascular dementia: association with education. BMJ, 310, 970-973, 1995.
31. Patterson M.B., Mack J.L., Mackell J.A., Thomas R., Tariot P., Weiner M., Whitehouse P.J., and the Alzheimer's Disease Cooperative Study: A Longitudianl Study of Behavioral Pathology Across Five Levels of Dementia Severity in Alzheimer's Disease: The CERAD Behavior Rating Scale for Dementia. Alzheimer Disease and Associated Disorders, 11 (Suppl 2), 40-44, 1997.
32. Pfeffer R.I., Kurosaki T.T., Harrah C.H. JR, Chance J.M., Filos S.: Measurement of functional activities in older adults in the community. J Gerontol, 37(3), 323-329, 1982. (Pubitemid 12117513)
33. Reiman E.M., Caselli R.J., Yun L.S., Chen K., Bandy D., Minoshima S., Thibodeau S.N., Osborne D.: Preclinical evidence of Alzheimer's disease in persons homozygous for the epsilon 4 allele for apolipoprotein E. N Engl J Med, 334(12), 752-758, 1996. (Pubitemid 26089356)
34. Reisberg B.: Dementia: a systematic approach to identifying reversible causes. Geriatrics, 41(4), 30-46, 1986.
35. Rumble B., Retallack R., Hilbich C., Simms G., Multhaup G., Martins R., Hockey A., Montgmery P., Beyreuther K., Masters C.L.: Amyloid A4 protein and its precursor in Down's syndrome and Alzheimer's disease. N Engl J Med, 320(22), 1446-1452, 1989. (Pubitemid 19143709)
36. Saunders A.M., Strittmatter W.J., Schmechel D., George-Hyslop P.H., Pericak-Vance M.A., Joo S.H., Rosi B.L., Gusella J.F., Crapper-MacLachlan D.R., Alberts M.J.: (1993) Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease. Neurology, 43(8), 1467-1472, 1993. (Pubitemid 23230526)
37. Schenk D., Barbour R., Dunn W., Gordon G., Grajeda H., Guido T., Hu K., Huang J., Johnson-Wood K., Khan K., Kholodenko D., Lee M., Liao Z., Lieberburg I., Motter R., Mutter L., Soriano F., Shopp G., Vasquez N., Vandevert C., Walker S., Wogulis M., Yednock T., Games D., Seubert P.: Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse. Nature, 400(6740), 173-177, 1999. (Pubitemid 29327547)
38. Selkoe D.J.: Cell biology of the amyloid beta-protein precursor and the mechanism of Alzheimer's disease. Annu Rev Cell Biol, 10, 373-403, 1994.
39. Sorbi S., Nacmias B., Forleo P., Piacentini S., Latorraca S., Amaducci L.: Epistatic effect of APP717 mutation and apolipoprotein E genotype in familial Alzheimer's disease. Ann Neurol, 38(1), 124-127, 1995.
40. Spiegel R., Brunner C., Ermini-Funfschilling D., Monsch A., Notter M., Puxty J., Tremmel L.: A new behavioral assessment scale for geriatric out- and in-patients: the NOSGER (Nurses' Observation Scale for Geriatric Patients). J Am Geriatr Soc, 39(4), 339-347, 1991.
41. Stähelin H.B. et al.: Diagnostik und Therapie der Alzheimer Krankheit - Ein Konsensus für die Schweiz. Schweizerische Ärztezeitung, im Druck, 1999.
42. Thalmann B., Monsch A.U., Ermini-Fünfschilling D., Stähelin H.B., Spiegel R.: Zeitzeich(n)en: Demenzscreening in der hausärztlichen Praxis. Geriatrie Praxis, 8(2), 31-32, 1997.
43. Van Broeckhoven C.L.: Molecular genetics of Alzheimer disease: Identification of genes and gene mutations. European Neurology, 35(1), 8-19, 1995.
44. Vassar R., Bennett B.D., Babu-Khan S., Kahn S., Mendiaz E.A., Denis P., Teplow D.B., Ross S., Amarante P., Loeloff R., Luo Y., Fisher S., Fuller J., Edenson S., Lile J., Jarosinski M.A., Biere A.L., Curran E., Burgess T., Louis J.C., Collins F., Treanor J., Rogers G., Citron M.: Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE. Science, 286(5440), 735-741,1999.
45. Yoshitake T., Kiyohara Y., Kato I., Ohmura T., Iwamoto H., Nakayama K., Ohmori S., Nomiyama K., Kawano H., Ueda K., et al.: Incidence and risk factors of vascular dementia and Alzheimer's disease in a defined elderly Japanese population: The Hisayama Study. Neurology, 45, 1161-1168, 1995.